Episode
đ€ AWS Summit : les entreprises doivent accĂ©lĂ©rer en IA (M. Denais, N. Morris, G. Cloix, S. Rubel)
- Published
- Apr 8, 2026
- Duration seconds
- 2451
- Processing state
processed- Canonical source
- đ€ IA : pourquoi les entreprises doivent accĂ©lĂ©rer maintenant (M. Denais, N. Morris, G. Cloix, S. Rubel)
Actions
POST https://stenobird.com/v1/public/podcasts/monde-num-rique-actualit-tech-ia-4060320/episodes/aws-summit-les-entreprises-doivent-acc-l-rer-en-ia-m-denais-n-morris-g-cloix-s-rubel/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/monde-num-rique-actualit-tech-ia-4060320/aws-summit-les-entreprises-doivent-acc-l-rer-en-ia-m-denais-n-morris-g-cloix-s-rubel.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Industry leaders discuss the shift from generative AI to agentic AI and its critical role in medical and industrial survival. The discussion highlights how specialized models and digital twins are transforming healthcare and business strategy.
Topics
- Artificial Intelligence
- Generative AI
- Agentic AI
- Digital Twins
- HealthTech
- Cloud Computing
- AWS Summit
- Biotechnology
- Digital Transformation
Highlights
- Main idea: The transition from generative AI to agentic AI is happening at an unprecedented speed, moving from simple chatbots to autonomous agents
- Practical takeaway: General-purpose LLMs often fail in specialized fields like psychiatry, requiring fine-tuned models trained on domain-specific clinical data
- Failure mode: Regulatory complexity and a lack of technical skills in Europe act as significant barriers to widespread AI deployment
- Main idea: Digital twins of the human body allow for simulating biological interactions to accelerate drug discovery and personalized treatment
- Strategic takeaway: AI adoption is no longer just about productivity; it is a fundamental requirement for maintaining competitive advantage and business survival
Chapters
1:00Clinical AI in Psychiatry: Martin Denais explains how Calliope uses voice and behavioral analysis to assist psychiatric decision-making.4:00Digital Twins for Drug Discovery: Nolwenn Morris discusses using neurosymbolic approaches to create human body simulations for personalized medicine.7:00The Power of Specialized Models: A deep dive into why open-source foundations must be adapted with proprietary clinical data to be effective.13:20The Crisis in Healthcare Adoption: Analyzing the gap between rising patient needs and the shortage of medical professionals and resources.22:30European Innovation Barriers: The challenges of funding, regulatory fragmentation, and the slow pace of public procurement in Europe.31:40Compliance and the Cost of AI: Discussing how a significant portion of tech budgets is consumed by compliance and regulatory obligations.34:50The Rise of Agentic AI: Exploring the next generation of AI agents that move beyond simple text summarization to complex task execution.